US Patent 7635701 Pyrimidine derivatives and their use as CB2 modulators
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Alan Naylor0
Andrew John Eatherton0
Andrew Richard Whittington0
Brian Peter Slingsby0
Derek Anthony Rawlings0
Gerard Martin Paul Giblin0
Richard Howard Green0
William Leonard Mitchell0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+312 characters)
Article
Patent abstract
The present invention relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07635701 Pyrimidine derivatives and their use as CB2 modulators US Patent 7635701 Pyrimidine derivatives and their use as CB2 modulators
Infobox
Patent Number
076357010
Patent Number
76357010
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076357010
Date of Patent
December 22, 2009
0Patent Application Number
105244700
Date Filed
August 19, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07635701 Pyrimidine derivatives and their use as CB2 modulators
Infobox
Is a
Patent jurisdiction
Patent number
07635701
Date of patent
December 22, 2009
Patent application number
10524470
Date Filed
August 19, 2003
Patent primary examiner
Find more entities like US Patent 7635701 Pyrimidine derivatives and their use as CB2 modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
